{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:19:43Z","timestamp":1786997983355,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.vhri.2024.101038","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T09:57:31Z","timestamp":1725011851000},"page":"101038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Economic Burden of Sickle Cell Disease in Saudi Arabia"],"prefix":"10.1016","volume":"45","author":[{"given":"Emad","family":"Shdaifat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Abu-Sneineh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagla","family":"Alsaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vhri.2024.101038_bib1","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Thomson","year":"2023","journal-title":"Lancet Haematol"},{"issue":"6 suppl 4","key":"10.1016\/j.vhri.2024.101038_bib2","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"Grosse","year":"2011","journal-title":"Am J Prev Med"},{"issue":"1","key":"10.1016\/j.vhri.2024.101038_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12955-019-1225-7","article-title":"Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study","volume":"17","author":"Shah","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"10.1016\/j.vhri.2024.101038_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4314\/ahs.v14i2.27","article-title":"The rate and cost of hospitalisation in children with sickle cell anaemia and its implications in a developing economy","volume":"14","author":"Adegoke","year":"2014","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.vhri.2024.101038_bib5","author":"Bouwmans"},{"issue":"4","key":"10.1016\/j.vhri.2024.101038_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s41669-022-00330-w","article-title":"Medical and non-medical costs of sickle cell disease and treatments from a US perspective: a systematic review and landscape analysis","volume":"6","author":"Baldwin","year":"2022","journal-title":"Pharmacoecon Open"},{"issue":"1","key":"10.1016\/j.vhri.2024.101038_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.36469\/jheor.2020.12852","article-title":"Medical resource use and costs of treating sickle cell-related vaso-occlusive crisis episodes: a retrospective claims study","volume":"7","author":"Shah","year":"2020","journal-title":"J\u00a0Health Econ Outcomes Res"},{"issue":"8","key":"10.1016\/j.vhri.2024.101038_bib8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jval.2021.02.014","article-title":"Indirect economic burden of sickle cell disease","volume":"24","author":"Holdford","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2024.101038_bib9","series-title":"Sickle cell disease associated with high costs in the Middle East","first-page":"28","volume":"884","year":"2021"},{"issue":"6 suppl","key":"10.1016\/j.vhri.2024.101038_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.HS9.0000821420.25455.37","article-title":"S113: cost of illness, epidemiology and healthcare resource utilization for sickle cell disease in gulf countries (CESCGU)","author":"Alkindi","year":"2022","journal-title":"Hemasphere"},{"key":"10.1016\/j.vhri.2024.101038_bib11","series-title":"Economic burden of sickle cell disease in the Middle East","author":"Ezzat","year":"2021"},{"key":"10.1016\/j.vhri.2024.101038_bib12","first-page":"69","article-title":"Knowledge and awareness of sickle cell anemia: cross sectional study among the general population in Saudi Arabia","author":"Khalifa","year":"2022","journal-title":"Biomed J"},{"issue":"3","key":"10.1016\/j.vhri.2024.101038_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/bloodadvances.2021006281","article-title":"Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance","volume":"7","author":"Johnson","year":"2023","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.vhri.2024.101038_bib14","first-page":"85","article-title":"Determinants of public healthcare expenditure in Saudi Arabia","volume":"3","author":"El-Farouk","year":"2016","journal-title":"Eur J Pharm Med Res"},{"issue":"10","key":"10.1016\/j.vhri.2024.101038_bib15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.26719\/2011.17.10.784","article-title":"undefined, 2011 undefined. Health care system in Saudi Arabia: an overview","volume":"17","author":"Almalki","year":"2011","journal-title":"East Mediterr Health J"},{"issue":"3","key":"10.1016\/j.vhri.2024.101038_bib16","first-page":"15","article-title":"Sickle-cell anemia and consanguinity among the Saudi Arabian population","volume":"8","author":"Zaini","year":"2016","journal-title":"Arch Med (Oviedo)"},{"issue":"2","key":"10.1016\/j.vhri.2024.101038_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jegh.2016.12.006","article-title":"Sickle cell disease in Saudi Arabia: a challenge or not","volume":"7","author":"Alotaibi","year":"2017","journal-title":"J\u00a0Epidemiol Glob Health"},{"issue":"1","key":"10.1016\/j.vhri.2024.101038_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-018-0657-9","article-title":"Methods of sample size calculation in descriptive retrospective burden of illness studies","volume":"19","author":"Johnston","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vhri.2024.101038_bib19","author":"Bouwmans"},{"issue":"2","key":"10.1016\/j.vhri.2024.101038_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.repc.2020.05.019","article-title":"Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal","volume":"40","author":"Marques","year":"2021","journal-title":"Rev Port Cardiol"},{"issue":"14","key":"10.1016\/j.vhri.2024.101038_bib21","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.3390\/ijerph18147232","article-title":"The institute for medical technology assessment productivity cost questionnaire (iPCQ) and the medical consumption questionnaire (iMCQ): translation and cognitive debriefing of the Arabic version","volume":"18","author":"Al-Aqeel","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"10.1016\/j.vhri.2024.101038_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3390\/medicina55050182","article-title":"The landscape of chronic pain: broader perspectives","volume":"55","author":"Johnson","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.vhri.2024.101038_bib23","series-title":"Torrance. Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"4","key":"10.1016\/j.vhri.2024.101038_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s41669-022-00330-w","article-title":"Medical and non-medical costs of sickle cell disease and treatments from a US perspective: a systematic review and landscape analysis","volume":"6","author":"Baldwin","year":"2022","journal-title":"Pharmacoecon Open"},{"issue":"4","key":"10.1016\/j.vhri.2024.101038_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.26719\/emhj.19.049","article-title":"The public health care system and primary care services in Saudi Arabia: a system in transition","volume":"26","author":"Asmri","year":"2020","journal-title":"East Mediterr Health J"},{"issue":"3","key":"10.1016\/j.vhri.2024.101038_bib26","first-page":"83","article-title":"An analysis of the Saudi health-care system\u2019s readiness to change in the context of the Saudi National Health-care Plan in Vision 2030","volume":"12","author":"Alharbi","year":"2018","journal-title":"Int J Health Sci"},{"issue":"2","key":"10.1016\/j.vhri.2024.101038_bib27","first-page":"4","article-title":"Healthcare financing in Saudi Arabia: recent trend and future challenges","volume":"21","author":"Alharbi","year":"2022","journal-title":"Online J Health Allied Sci"},{"key":"10.1016\/j.vhri.2024.101038_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/IJGM.S393233","article-title":"The burden of sickle cell disease in Saudi Arabia: a single-institution large retrospective study","volume":"16","author":"Zuair","year":"2023","journal-title":"Int J Gen Med"},{"issue":"2","key":"10.1016\/j.vhri.2024.101038_bib29","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1353\/hpu.2018.0060","article-title":"Social and behavioral factors in sickle cell disease: employment predicts decreased health care utilization","volume":"29","author":"Williams","year":"2018","journal-title":"J\u00a0Health Care Poor Underserved"},{"issue":"9","key":"10.1016\/j.vhri.2024.101038_bib30","first-page":"833","article-title":"Daily functioning and quality of life in children with sickle cell disease pain: relationship with family and neighborhood socioeconomic distress","volume":"9","author":"Palermo","year":"2008","journal-title":"J\u00a0Pain"},{"issue":"3","key":"10.1016\/j.vhri.2024.101038_bib31","first-page":"405","article-title":"A\u00a0comparative study of academic achievement of children with sickle cell anemia and their healthy siblings","volume":"97","author":"Ogunfowora","year":"2005","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"12","key":"10.1016\/j.vhri.2024.101038_bib32","article-title":"Prevalence of psychological symptoms and its impact on the quality of life of sickle cell disease patients in Makkah, Saudi Arabia","volume":"14","author":"Dairi","year":"2022","journal-title":"Cureus"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109924000712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T19:21:19Z","timestamp":1739215279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109924000712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":32,"alternative-id":["S2212109924000712"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101038","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic Burden of Sickle Cell Disease in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2024.101038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101038"}}